| SUBSCRIBE | BECOME A MEMBER | JOBS

HEAL webinar series on the health impacts of per- and polyfluoroalkyl substances

Short for per- and polyfluoroalkyl substances, PFAS are also called “forever chemicals” because they can take up to 1,000 years to break down in the environment with some not breaking down at all. These chemicals can be found in many consumer products, such as non-stick frying pans, food packaging, and cosmetics. Scientific evidence has linked PFAS exposure to numerous serious health impacts, including different types of cancer, immune dysfunction and hormone disruption. The EU is currently working to restrict the use of PFAS. 

To raise awareness of the impacts of PFAS on human health, HEAL organises a webinar series on the topic, with leading experts in the field exploring the various health effects of PFAS exposure. The first webinar, held in October 2024, focused on the impacts of PFAS on the immune system, and the second held in November 2024 focused on PFAS exposure in early life and pregnancy, with the subsequent one focusing on PFAS and its links to cancer. Recordings of the webinars will be made available below.

Save the date!

Webinar: PFAS and cancer

23.1.2025 – More information and registration coming up soon!

Past webinars:

PFAS exposure during pregnancy and early life

Nikolaos (Nikos) Stratakis, PhD, MSc is a postdoctoral researcher with expertise in exposome science and its role in childhood metabolic health. He holds a PhD in Epidemiology from Maastricht University and an MSc in Nutritional Medicine from the University of Surrey, and partner in ATHLETE (an EU-funded project aiming to better understand and prevent the effects of environmental hazards on human health from preconception until adolescence). Dr. Stratakis focuses on the complex interactions between environmental exposures and biological pathways that contribute to metabolic diseases, such as metabolic-associated steatotic liver disease. Currently a Marie Skłodowska-Curie fellow at the Barcelona Institute for Global Health (ISGlobal), he combines exposome analysis with multi-omics in population-based birth cohorts to identify early-life environmental determinants of liver disease risk. Dr. Stratakis has published widely in leading journals, and his work seeks to integrate exposome data with molecular profiling to inform precision environmental health strategies for chronic disease prevention across the life course. In this webinar, Mr Stratakis delves into the long-term impacts of PFAS with insights into the link between early-life PFAS and childhood metabolic health.

Research indicates that maternal exposure to PFAS may disrupt key metabolic pathways in offspring, contributing to potential health issues such as obesity and cardiovascular disease later in life. Early life exposure to these ‘forever chemicals’ heightens the urgency to minimize contact during critical development stages to safeguard children’s future health.

Impacts of PFAS on the immune system

Philippe Grandjean, MD, PhD, dr.h.c. is Professor of Environmental Medicine at the University of Southern Denmark and Research Professor at the University of Rhode Island. He previously served for 30 years as advisor on toxicology at the Danish Health Authority and for 20 years as Adjunct Professor at Harvard School of Public Health. His recent research on environmental epidemiology has focused on perfluorinated substances. His research has inspired the lowering of PFAS exposure limits in the EU and the US.  In this webinar, Professor Grandjean presents his work on the impacts of PFAS on vaccine responses, and the implications for immunity against infectious diseases:

Studies show that PFAS exposure weakens the immune system, leading to a reduced response to vaccines, particularly in children. This is a very alarming finding, as it leaves people vulnerable to disease. These chemicals are almost everywhere, and they remain in the body for years, accumulating with each exposure. We must take preventive action”

 

 

More resources on PFAS: 

  • For more information on how PFAS pollution affects communities across Europe and resources on PFAS, visit HEAL’s PFAS website. 

Related Posts

HEAL assessment of the trio hearings of Vice-President-designate Ribera, Vice-President-designate Séjourné and Commissioner-designate Hoekstra
Over the past days, MEPs held confirmation hearings with Vice-President-designate Ribera, Vice-President-designate Séjourné and Commissioner-designate Hoekstra, whose complementary and mutually enabling portfolios respectively focus on “Clean, Just and Competitive Transition”, “Prosperity and Industrial Strategy” and “Climate, Net-Zero and Clean Growth”.  HEAL was encouraged to see strong coherence among the three designates on their shared commitment to protecting health against this triple crisis.  
Advocating for a European future free of endocrine-disrupting chemicals
HEAL, alongside the EDC-Free Europe coalition, is asking future EU leaders to protect health and the environment from the health-harming endocrine-disrupting chemicals (EDCs). The recently published EDC-Free Europe statement ‘7 priorities to protect people and environment from harm caused by endocrine-disrupting chemicals outlines crucial steps that policymakers must take to protect public health and the environment from these harmful substances.
Back To Top